PURPOSE: Androgen deprivation therapy has a variety of well recognized adverse effects
including vasomotor flushing, loss of libido, fatigue, gynecomastia, anemia and …

Abstract Context: Prostate cancer (PCa) is the most common cancer in men. Androgen-
deprivation therapy (ADT) is generally employed in the treatment of locally advanced and …

Metabolic sequelae associated with androgen deprivation ther... : Current Opinion in
Endocrinology, Diabetes and Obesity Metabolic sequelae associated with androgen deprivation …

Androgen deprivation therapy for prostate cancer: new concep... : Current Opinion in
Endocrinology, Diabetes and Obesity Androgen deprivation therapy for prostate cancer: new …

Prostate cancer is the leading cancer diagnosis and second leading cause of cancer‐
related mortality for men in the United States. Due to the increased prevalence of prostate …

OBJECTIVES: Previous research has documented an increase in metabolic syndrome
among patients who use androgen-deprivation therapy (ADT). Given that metabolic …

Androgen-deprivation therapy (ADT) entails lowering serum testosterone levels to castrate
levels and forms a cornerstone of the management of hormone-sensitive advanced prostate …

Purpose Androgen deprivation therapy with a gonadotropin-releasing hormone (GnRH)
agonist is associated with increased fat mass and insulin resistance in men with prostate …

Prostate cancer (PCa) is the most common cancer in men. Androgen deprivation therapy
(ADT) is used in the treatment of locally advanced and metastatic PCa. Although its use as …

Adverse effects of androgen deprivation therapy (ADT) are a consequence of the induced
sex steroid deficiency. ADT increases fat mass leading to insulin resistance and diabetes …